Trends in Anti-Influenza Drug Prescription and Adverse Drug Reaction Reporting After the Lifting of Oseltamivir Prescribing Restrictions in Pediatric Outpatients: An Ecological Study Using the MDV Analyzer® And the Japanese Adverse Drug Event Report Database

• Главные авторы: Misaki Tokunaga (Автор), Daisuke Kikuchi (Автор), Aoi Noda (Автор), Sachiko Oikawa (Автор), Makoto Shiozawa (Автор), Hiroaki Hino (Автор), Ryosuke Miura (Автор), Kensuke Usui (Автор), Taku Obara (Автор), Kouji Okada (Автор)
• Формат: ‌
• Опубликовано: Adis, Springer Healthcare, 2024-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Background Abnormal behavior after oseltamivir administration has been reported in the media; in 2007, the package insert for oseltamivir phosphate was revised to restrict its administration to individuals aged over 10 years. However, in 2018, the age limitation specified in the package ins...